Segasist Technologies, a Canadian software company developing contouring productivity tools for medical imaging, has received funding from The Health Technology Exchange (HTX) towards support of clinical validation of its PMR-R software, to be conducted at the Lawson Health Research Institute and London Health Sciences Centre (London, Ontario).

Segasist PMR-R is a software tool developed for the purpose of processing Magnetic Resonance Images (MRI) of the prostate.

The funding received from HTX will augment grants from other sources to enable a pre-calibrated version of Segasist PMR-R to be validated with the ultimate goal of releasing Segasist PMR-C for clinical use following regulatory approval.

Segasist said that Version 1.0 was created to assist researchers presently developing a role for MRI in diagnosis, tracking and treatment of prostate cancer.

Segasist Technologies CEO Hamid Tizhoosh said that the purpose of the validation process will be to show that the Segasist PMR platform offers significant time savings for clinicians performing image segmentation and volume calculations, as well as a high level of semi-automated contouring accuracy.

"Segasist PMR is the first commercial software of its kind providing a complete solution for segmentation and volumetric measurements of the prostate gland in MR images," Tizhoosh said.